B. Pitrosky

972 total citations
29 papers, 647 citations indexed

About

B. Pitrosky is a scholar working on Endocrine and Autonomic Systems, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, B. Pitrosky has authored 29 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrine and Autonomic Systems, 9 papers in Cellular and Molecular Neuroscience and 8 papers in Pharmacology. Recurrent topics in B. Pitrosky's work include Circadian rhythm and melatonin (18 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (8 papers) and Treatment of Major Depression (8 papers). B. Pitrosky is often cited by papers focused on Circadian rhythm and melatonin (18 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (8 papers) and Treatment of Major Depression (8 papers). B. Pitrosky collaborates with scholars based in France, United States and United Kingdom. B. Pitrosky's co-authors include Paul Pévet, R. Kirsch, Karen A. Tourian, А. Малан, B. Vivien‐Roels, Helge A. Slotten, B. Canguilhem, E. Mocaër, Jean‐Michel Germain and Sandrine Schuhler and has published in prestigious journals such as Brain Research, Annals of the New York Academy of Sciences and Behavioural Brain Research.

In The Last Decade

B. Pitrosky

29 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Pitrosky France 16 389 205 178 156 150 29 647
E. Salvati France 13 481 1.2× 64 0.3× 64 0.4× 106 0.7× 162 1.1× 21 757
Gillin Jc United States 15 118 0.3× 210 1.0× 103 0.6× 86 0.6× 220 1.5× 35 652
Vahab Babapour Iran 19 391 1.0× 410 2.0× 77 0.4× 185 1.2× 174 1.2× 70 874
Isabel C. Sumaya United States 11 259 0.7× 94 0.5× 37 0.2× 73 0.5× 132 0.9× 13 433
Alejandra E. Ruiz‐Contreras Mexico 14 99 0.3× 261 1.3× 375 2.1× 45 0.3× 196 1.3× 54 654
Marco Antonio Campana Benedito Brazil 13 120 0.3× 249 1.2× 144 0.8× 55 0.4× 135 0.9× 26 575
David S. Janowsky United States 13 123 0.3× 284 1.4× 53 0.3× 79 0.5× 110 0.7× 23 690
Ajda Yılmaz Netherlands 7 147 0.4× 148 0.7× 123 0.7× 74 0.5× 94 0.6× 12 398
John P. Braselton United States 11 173 0.4× 290 1.4× 43 0.2× 90 0.6× 111 0.7× 17 766
Jenny Redman Australia 6 667 1.7× 216 1.1× 24 0.1× 198 1.3× 269 1.8× 6 756

Countries citing papers authored by B. Pitrosky

Since Specialization
Citations

This map shows the geographic impact of B. Pitrosky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Pitrosky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Pitrosky more than expected).

Fields of papers citing papers by B. Pitrosky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Pitrosky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Pitrosky. The network helps show where B. Pitrosky may publish in the future.

Co-authorship network of co-authors of B. Pitrosky

This figure shows the co-authorship network connecting the top 25 collaborators of B. Pitrosky. A scholar is included among the top collaborators of B. Pitrosky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Pitrosky. B. Pitrosky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tourian, Karen A., et al.. (2011). A 10-Month, Open-Label Evaluation of Desvenlafaxine in Outpatients With Major Depressive Disorder. The Primary Care Companion For CNS Disorders. 13(2). 11 indexed citations
2.
Tourian, Karen A., et al.. (2011). A 10-Month, Open-Label Evaluation of Desvenlafaxine in Outpatients With Major Depressive Disorder. The Primary Care Companion For CNS Disorders. 2 indexed citations
3.
Rickels, Karl, Stuart Montgomery, Karen A. Tourian, et al.. (2010). Desvenlafaxine for the Prevention of Relapse in Major Depressive Disorder. Journal of Clinical Psychopharmacology. 30(1). 18–24. 28 indexed citations
4.
Bech, Per, P Boyer, Krishna Padmanabhan, et al.. (2010). HAM-D17and HAM-D6Sensitivity to Change in Relation to Desvenlafaxine Dose and Baseline Depression Severity in Major Depressive Disorder. Pharmacopsychiatry. 43(7). 271–276. 28 indexed citations
5.
Reddy, Sujana, Cecelia P. Kane, B. Pitrosky, et al.. (2009). Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician. Current Medical Research and Opinion. 26(1). 139–150. 7 indexed citations
6.
Lieberman, Daniel Z., Stuart Montgomery, Karen A. Tourian, et al.. (2008). A pooled analysis of two placebo-controlled trials of desvenlafaxine in major depressive disorder. International Clinical Psychopharmacology. 23(4). 188–197. 50 indexed citations
7.
Pitrosky, B., et al.. (2007). A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder. International Clinical Psychopharmacology. 22(6). 338–347. 81 indexed citations
8.
Lydiard, R. Bruce, B. Pitrosky, David Hackett, & Carla White. (2004). Impact of Gastrointestinal Symptom Severity on Response to Venlafaxine Extended-Release in Patients With Generalized Anxiety Disorder. The Journal of Clinical Psychiatry. 65(6). 838–844. 7 indexed citations
9.
Sicard, B., Béatrice Bothorel, B. Pitrosky, et al.. (2004). Environmental control and adrenergic regulation of pineal activity in the diurnal tropical rodent, Arvicanthis ansorgei. Journal of Pineal Research. 38(3). 189–197. 10 indexed citations
10.
Pitrosky, B., Philippe Delagrange, Marie‐Claire Rettori, & Paul Pévet. (2003). S22153, a melatonin antagonist, dissociates different aspects of photoperiodic responses in Syrian hamsters. Behavioural Brain Research. 138(2). 145–152. 10 indexed citations
11.
Slotten, Helge A., B. Pitrosky, & Paul Pévet. (2002). Entrainment of Rat Circadian Rhythms by Daily Administration of Melatonin. Advances in experimental medicine and biology. 460. 279–281. 9 indexed citations
12.
Challet, Étienne, B. Pitrosky, B. Sicard, André Malan, & Paul Pévet. (2002). Circadian Organization in a Diurnal Rodent, Arvicanthis ansorgei Thomas 1910: Chronotypes, Responses to Constant Lighting Conditions, and Photoperiodic Changes. Journal of Biological Rhythms. 17(1). 52–64. 48 indexed citations
13.
Slotten, Helge A., B. Pitrosky, Sturla Krekling, & Paul Pévet. (2002). Entrainment of Circadian Activity Rhythms in Rats to Melatonin Administered at T Cycles Different from 24 Hours. Neurosignals. 11(2). 73–80. 12 indexed citations
14.
Slotten, Helge A., B. Pitrosky, & Paul Pévet. (2000). Entrainment of rat circadian rhythms by melatonin does not depend on the serotonergic afferents to the suprachiasmatic nuclei. Brain Research. 876(1-2). 10–16. 7 indexed citations
15.
16.
17.
Schuhler, Sandrine, Michel Saboureau, B. Pitrosky, & Paul Pévet. (1998). In Syrian hamsters, 5-HT fibres within the suprachiasmatic nuclei are necessary for the expression of 8-OH-DPAT induced phase-advance of locomotor activity rhythm. Neuroscience Letters. 256(1). 33–36. 24 indexed citations
18.
Pitrosky, B. & Paul Pévet. (1997). The Photoperiodic Response in Syrian Hamsters Depends upon a Melatonin-Driven Rhythm of Sensitivity to Melatonin. Neurosignals. 6(4-6). 264–271. 15 indexed citations
19.
Vivien‐Roels, B., et al.. (1997). Environmental Control of the Seasonal Variations in the Daily Pattern of Melatonin Synthesis in the European Hamster,Cricetus cricetus. General and Comparative Endocrinology. 106(1). 85–94. 38 indexed citations
20.
Pévet, Paul, B. Pitrosky, Patrick Vuillez, et al.. (1996). Chapter 24 The suprachiasmastic nucleus: the biological clock of all seasons. Progress in brain research. 111. 369–384. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Salvati Breakdown of academic impact, for papers by Gillin Jc Breakdown of academic impact, for papers by Vahab Babapour Breakdown of academic impact, for papers by Isabel C. Sumaya Breakdown of academic impact, for papers by Alejandra E. Ruiz‐Contreras Breakdown of academic impact, for papers by Marco Antonio Campana Benedito Breakdown of academic impact, for papers by David S. Janowsky Breakdown of academic impact, for papers by Ajda Yılmaz Breakdown of academic impact, for papers by John P. Braselton Breakdown of academic impact, for papers by Jenny Redman
Rankless by CCL
2026